1. Home
  2. OSS vs GALT Comparison

OSS vs GALT Comparison

Compare OSS & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo One Stop Systems Inc.

OSS

One Stop Systems Inc.

N/A

Current Price

$9.10

Market Cap

197.3M

Sector

Technology

ML Signal

N/A

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

N/A

Current Price

$2.84

Market Cap

199.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSS
GALT
Founded
1998
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.3M
199.2M
IPO Year
2017
2008

Fundamental Metrics

Financial Performance
Metric
OSS
GALT
Price
$9.10
$2.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$10.00
$8.50
AVG Volume (30 Days)
1.5M
349.4K
Earning Date
03-18-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
133.85
N/A
EPS
0.22
N/A
Revenue
$37,027,382.00
N/A
Revenue This Year
$13.57
N/A
Revenue Next Year
$23.40
N/A
P/E Ratio
$40.23
N/A
Revenue Growth
34.46
N/A
52 Week Low
$1.85
$1.15
52 Week High
$12.75
$7.13

Technical Indicators

Market Signals
Indicator
OSS
GALT
Relative Strength Index (RSI) 46.76 43.60
Support Level $7.95 $2.57
Resistance Level $10.74 $3.32
Average True Range (ATR) 0.96 0.23
MACD -0.05 -0.02
Stochastic Oscillator 22.80 25.00

Price Performance

Historical Comparison
OSS
GALT

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: